Search results for " cost"
Article
Taking a “Development-by-Design” Approach to Cell Therapies
Automating processes is key to reducing costs (courtesy of Invetech).
“We are not trying to be two different companies, and we do not see the two competing with each other,” says Mazzo in an int…
Article
Optimizing Resin Performance with Disposable Chromatography Solutions
The experts addressed how disposable chromatography columns can be used throughout the life of a campaign, the costs and benefits associated with using prepacked columns, the complexities of resin str…
Article
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
…gh (particularly for ‘older’ drugs that are outside the 12-year statutory exclusivity term), the costs of establishing interchangeability are also high. Biosimilar applicants seeking to pursue interc…
Article
Challenges and Trends in Biopharma Facility Design
“Global deployment, cost pressure, time to market, and change/uncertainty” are some of the factors biopharma companies need to consider, according to Par Almhem, president of Modwave. And, the trend t…
Article
Operational Excellence: More Than Just Process Improvement
Life-sciences companies face more pressure than ever to reduce costs and increase efficiency. The pressures are many and relentless: price constraints, global competition, product complexity, and more…
Article
The Challenge of Disruptive Technologies in Bioprocessing
The high cost, or perceived cost, of an established technology is another driver. An example of the latter may be the use of affinity chromatography in the capture step of antibody processes, Jagschie…
Article
Making the Move to Continuous Chromatography
Some regulatory aspects must still be addressed, however, and for companies with extensive existing infrastructure, switching to continuous chromatography might not be cost-effective.
Continuous v…
Article
Biopharma Advances Demand Specialized Expertise
BioPharm: What is the greatest technical challenge facing biopharmaceutical companies today?
Hartzel (Catalent Pharma Solutions): Cost to manufacture will continue to be a major challenge for the i…
Article
Addressing the Challenges in Downstream Processing Today and Tomorrow
The standardization of cellular expression systems, bioreactor conditions, purification processes, manufacturing hardware, and disposables has resulted in faster clinical development and lower costs. …
Article
Methods Accelerate Biosimilar Analysis
Currently, the development of biosimilars is lengthy, taking up to seven years to gain approval; the effort is relatively expensive, costing between $150–$200 million per biosimilar product. Identifyi…